KROGNES STEVE E. (CFO and Treasurer) received a stock award from DENALI THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2026ACC: 0001666236-26-000015
Officer· CFO and Treasurer
Since Aug 2018
+25.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
25.63K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.41K
Price / share
—
Trade value
—
% of position
20.2%
6/3/2026
31.79K→38.20K
Total
Net shares
+6.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | A · Award | +6.41K | — | — | 20.2% | 31.79K | 38.20K |
| Total | +6.41K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
19.23K shares
Shares
+19.23K
Strike price
19.66
Held after
19.23K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock19.23K shares | 6/3/2026 | A · Award | +19.23K | 19.66 | — | 19.23K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned781.80K
Total
781.80K indirect781.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 781.80K | Indirect |
| Total | 781.80K | 781.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported